CLOSE comprises a pan-European consortium
The consortium behind CLOSE is diverse and mutually reinforcing. Profil GmbH – a full-service CRO for early clinical trials in diabetes, obesity and cardiometabolic disease – coordinates the CLOSE initiative in collaboration with Air Liquide Healthcare and is supported by EURICE GmbH. Profil GmbH is a co-founder of the EIT Health Knowledge and Innovation Community – the network of top-of-the-range health innovators supported by the European Union.
CLOSE partners hold key capabilities in healthcare service provision, AP development and clinical evaluation, education & training, performance measurement, as well as at market implementation and advancement of diabetes technologies. In addition, expertise in healthcare research, economic modelling, and the development of performance measurement instruments is available within the partnership. The CLOSE partnership has been established and received funding under the umbrella of EIT Health. There are close collaborations with other European initiatives including D4Kids, D4Teens, AP@home, and RealWorld4Clinic.
CLOSE Partners:
Profil, Profil Mainz, Air Liquide Healthcare, Sanofi, Catholic University of Leuven, Medical University of Lodz, IESE Business School, aQua Institute, European Research and Project Office (EURICE).
CLOSE Advisory Board:
CLOSE receives valuable advice from the CLOSE Advisory Board members Prof. Dr Eric Renard (Centre Hospitalier Universitaire de Montpellier, Department of Endocrinology, Diabetes and Nutrition), Prof. Dr Yves Reznik (Centre Hospitalier Universitaire de Caen, Service d’Endocrinologie) and Prof. Dr Lutz Heinemann (Science Consulting in Diabetes GmbH).